HomeCompareDRTGF vs JNJ

DRTGF vs JNJ: Dividend Comparison 2026

DRTGF yields 1.49% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DRTGF wins by $186.00 in total portfolio value
10 years
DRTGF
DRTGF
● Live price
1.49%
Share price
$15.07
Annual div
$0.22
5Y div CAGR
27.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$2,464.29
Full DRTGF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — DRTGF vs JNJ

📍 DRTGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDRTGFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DRTGF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DRTGF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DRTGF
Annual income on $10K today (after 15% tax)
$126.63/yr
After 10yr DRIP, annual income (after tax)
$2,094.65/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $1,891.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DRTGF + JNJ for your $10,000?

DRTGF: 50%JNJ: 50%
100% JNJ50/50100% DRTGF
Portfolio after 10yr
$30.4K
Annual income
$3,576.84/yr
Blended yield
11.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DRTGF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
3.9
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DRTGF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDRTGFJNJ
Forward yield1.49%2.13%
Annual dividend / share$0.22$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR27.8%28%
Portfolio after 10y$30.5K$30.3K
Annual income after 10y$2,464.29$4,689.40
Total dividends collected$9.1K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: DRTGF vs JNJ ($10,000, DRIP)

YearDRTGF PortfolioDRTGF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,890$190.40$10,592$272.30+$298.00DRTGF
2$11,900$247.66$11,289$357.73+$611.00DRTGF
3$13,057$323.23$12,123$472.89+$934.00DRTGF
4$14,394$423.58$13,141$629.86+$1.3KDRTGF
5$15,960$557.75$14,408$846.81+$1.6KDRTGF
6$17,815$738.61$16,021$1,151.60+$1.8KDRTGF
7$20,047$984.78$18,122$1,588.22+$1.9KDRTGF
8$22,774$1,323.56$20,930$2,228.20+$1.8KDRTGF
9$26,164$1,795.88$24,792$3,191.91+$1.4KDRTGF
10$30,460$2,464.29$30,274$4,689.40+$186.00DRTGF

DRTGF vs JNJ: Complete Analysis 2026

DRTGFStock

Jet2 plc, together with its subsidiaries, engages in the leisure travel business in the United Kingdom. The company operates scheduled holiday flights to leisure destinations in the Mediterranean, the Canary Islands, and European Leisure Cities. It is also involved in the package holiday and non-ticket retail activities, as well as passenger and charter aircraft operations. The company was formerly known as Dart Group PLC and changed its name to Jet2 plc in September 2020. Jet2 plc was founded in 1971 and is based in Leeds, the United Kingdom.

Full DRTGF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this DRTGF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DRTGF vs SCHDDRTGF vs JEPIDRTGF vs ODRTGF vs KODRTGF vs MAINDRTGF vs ABBVDRTGF vs MRKDRTGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.